mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.0096 |
0.9 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
0.0095 |
0.9 |
mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.0094 |
0.9 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.01 |
0.9 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.9 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |